Quantcast
Last updated on April 16, 2014 at 12:26 EDT

Latest Medivisor Inc. Stories

2008-09-25 09:00:54

Medivisor, Inc. (PINKSHEETS: MVSR) announced today that Albumax has been approved by the California and the Pennsylvania State Medicaid Offices. Albumax has previously received approval from the New York State Medicaid Office. Albumax has been approved under code B4155 as an enteral product. This approval allows for Medicaid reimbursement of costs for eligible patients using Albumax. Medicaid is the largest source of funding for medical and health-related services for people with limited...

2008-09-24 09:00:49

Medivisor, Inc. (PINKSHEETS: MVSR) developer of next-generation, focus driven marketing tools primarily for pharmaceutical companies, is pleased to announce that it has received a purchase order for Albumax from Critical Healthcare Solutions, Inc. for their East Goshen Pharmacy Inc. unit. "After completing our sales and marketing agreement for Albumax just a few weeks ago, our initial marketing efforts are already starting to pay off. We are already beginning to see a strong interest in the...

2008-09-12 09:00:51

Medivisor, Inc. (PINKSHEETS: MVSR) announced today that Albumax has been approved by the New York State Medicaid Office. Albumax has been approved under code B4155 as an enteral product. The approval is significant in that it allows for Medicaid reimbursement of costs for eligible patients using Albumax. Medicaid is the largest source of funding for medical and health-related services for people with limited income. It is an entitlement program that is jointly funded by the states and...

2008-09-05 09:00:08

Medivisor, Inc. (PINKSHEETS: MVSR) announced today that it has signed an agreement with Cura Pharmaceutical, Co. Inc to market the product Albumax, a whey protein isolate formula that makes it easy for kidney disorder patients to reach their daily requirements of high quality protein in their diet. Under the terms of the Agreement, Cura will continue to be responsible for manufacturing, regulatory, medical, clinical development, pricing and distribution for the product while Medivisor is...

2008-09-03 09:00:46

Medivisor Inc. (PINKSHEETS: MVSR) announced today that it has signed a revenue sharing agreement for the marketing and sale of LIPIDEME(TM) with PanGenex Corporation (PINKSHEETS: PGXC). PanGenex develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions. PanGenex focuses specifically on the cardiovascular...

2008-07-24 09:01:13

Medivisor Inc. (PINKSHEETS: MVSR) today announced that it has signed a new sales and marketing agreement with Cura Pharmaceutical for the marketing of Mucotrol(TM) in the United States. The groundbreaking drug Mucotrol(TM) is an oral gel wafer that received 510-K approval as a device from the FDA in late November 2004, as a treatment for mouth sores related to chemotherapy. Cura will supply and distribute Mucotrol(TM) with Medivisor handling the marketing and sales. Under the terms of the...